---
schema_version: "secwatch.filing_event.v1"
accession: "0001437749-25-030813"
form_type: "8-K"
ticker: "AURX"
cik: "0001091596"
company_name: "Nuo Therapeutics, Inc."
filed_at: "2025-10-10T23:59:59+00:00"
generated_at: "2026-05-17T04:03:25.429309+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.15
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# Nuo Therapeutics raises CEO and COO salaries, sets Dec 16 annual meeting

## Summary
- CEO David E. Jorden salary increased to $325,000 effective Oct 1, 2025.
- COO Peter A. Clausen salary increased to $290,000 effective same date.
- Annual meeting scheduled for Dec 16, 2025 at Houston principal executive office.
- Shareholder proposals and director nominations deadline is Oct 20, 2025.

## SEC filing metadata
- accession: 0001437749-25-030813
- form_type: 8-K
- ticker: AURX
- cik: 0001091596
- company_name: Nuo Therapeutics, Inc.
- filed_at: 2025-10-10T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.15
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.02, 5.08, 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1091596/000143774925030813/0001437749-25-030813-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1091596/000143774925030813/aurx20251009_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001437749-25-030813
- JSON: https://secwatch.observer/filing/0001437749-25-030813.json
- Plain text: https://secwatch.observer/filing/0001437749-25-030813.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.